RecruitingNCT07186699

Qualitative Study on Detection & Tx of NSCLC in Pts w/ a History of Alcohol or SUD

Qualitative Study on Detection and Treatment of Non-Small Cell Lung Cancer in Patients With a History of Alcohol or Substance Use Disorder

Sponsor

University of Southern California

Enrollment

45 participants

Start Date

Sep 29, 2025

Study Type

OBSERVATIONAL

Conditions

Lung Non-Small Cell Carcinoma

Summary

This study will attempt to identify social facilitators and barriers to detection and treatment of non-small cell lung cancer in order to learn how a history of substance abuse or alcohol use impacts care for non-small cell lung cancer.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This qualitative research study is interviewing non-small cell lung cancer (NSCLC) patients who also have a history of alcohol or substance use disorder to understand their experiences with cancer diagnosis and treatment. It aims to find ways to improve care for this underserved group. **You may be eligible if...** - You are 18 or older and have a confirmed diagnosis of non-small cell lung cancer (NSCLC) - You received or are receiving treatment intended to cure the cancer - You have a history of alcohol or substance use disorder (not including tobacco) in the past 10 years, before your cancer diagnosis - You speak English or Spanish fluently **You may NOT be eligible if...** - You have a cognitive disability that prevents you from holding a 30–60 minute conversation Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNon-Interventional Study

Non-interventional study

Locations(2)

Los Angeles General Medical Center

Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07186699

Related Trials

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

NCT042678481149 locations

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

NCT06498635227 locations

Telisotuzumab Vedotin and Osimertinib for the Treatment of Progressive, Incurable, Non Small Cell Lung Cancer

NCT073236411 location

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

NCT0728803413 locations

Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers

NCT039481001 location